Full Text
PCV70 COST-EFFECTIVENESS OF ROSUVASTATIN 20 MG IN SECONDARYPREVENTION PATIENTS IN THE UNITED STATES

Abstract

Authors

R Ohsfeldt SK Gandhi MM Jensen L Smolen KM Fox J Hsia A Gold

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×